|
CN105193768A
|
|
Triamcinolone acetonide oral sticking tablet and preparation process thereof
|
|
CN105056246A
|
|
Carglumic acid solid composition and preparation method thereof
|
|
CN105130993A
|
|
Novel oxidation method for synthesis of alcaftadine
|
|
CN104987337A
|
|
Novel oxidation method for preparing alcaftadine
|
|
CN104800854A
|
|
Inhalant acetylcysteine solution and preparation method of inhalant acetylcysteine solution
|
|
CN104856990A
|
|
Phenylephrine ketorolac solution and preparation method
|
|
CN104860920A
|
|
Alcaftadine intermediate preparation method
|
|
CN104873519A
|
|
Travoprost composition for eyes and preparation method of travoprost composition
|
|
CN104490833A
|
|
Ezetimibe orally disintegrating tablet and preparation method thereof
|
|
CN104398486A
|
|
Ivabradine hydrochloride osmotic pump controlled-release tablet and preparation method thereof
|
|
CN104316619A
|
|
Method for analyzing and separating dorzolomide hydrochloride enantiomers by HPLC (high performance liquid chromatography) process
|
|
CN104316618A
|
|
Method for measuring L-cysteine content by HPLC (high performance liquid chromatography) process
|
|
CN104447474A
|
|
Synthetic method of ezetimibe isomer
|
|
CN104326959A
|
|
Preparation method of Ezetimibe isomer
|
|
CN104133019A
|
|
Method for detecting diazabicyclo nonane enantiomorphism isomers
|
|
CN104086478A
|
|
Impurity compound in tirofiban hydrochloride and preparation method of impurity compound
|
|
CN104042591A
|
|
Compound preparation comprising ketoprofen and omeprazole and preparation method thereof
|
|
CN103989630A
|
|
Moxifloxacin hydrochloride sodium chloride injection and preparation method thereof
|
|
CN103989660A
|
|
Azithromycin-containing slow-released eye drops and preparation method thereof
|
|
CN103837626A
|
|
Method for determining content of trifluoroacetic acid in bivalirudin
|
